AJMC - Change is Coming

News
Video
Podcasts
Journals
Conferences
Events
Resources
CE
About AJMC
Subscribe

Spotlight -

Free In-Person Regional Events Focused on Oncology and Population Health

Mason W. Russell, MAPE

Articles by Mason W. Russell, MAPE

Prevalence of Cardiovascular Disease Risk Factors Among US Adults With Self-Reported Osteoarthritis: Data from the Third National Health and Nutrition Examination Survey

ByGurkirpal Singh, MD,Jeffrey D. Miller, MS,Fleur H. Lee, MPH,Dan Pettitt, DVM, MSc,Mason W. Russell, MAPE

October 1st 2002

Use of Managed Care Claims Data in the Risk Assessment of Venous Thromboembolism in Outpatients

ByMason W. Russell, MAPE,Douglas C. A. Taylor, MBA,Gordon Cummins, MS,Daniel M. Huse, MA

January 1st 2002

Outpatient Treatment of Venous Thromboembolism with Low-Molecular-Weight Heparin: An Economic Evaluation

ByDaniel M. Huse, MA,Gordon Cummins, MS,Douglas C. A. Taylor, MBA,Mason W. Russell, MAPE

January 1st 2002

Anti-inflammatory Therapy Reduces Total Costs of Asthma Care Compared with Bronchodilation: The Asthma Outcomes Registry

ByDaniel M. Huse, MA,Mason W. Russell, MAPE,Scott T. Weiss, MD, MS,Stuart C. Hartz, ScD

September 1st 2000

Latest Updated Articles

Use of Managed Care Claims Data in the Risk Assessment of Venous Thromboembolism in Outpatients
Published: January 1st 2002 | Updated:
Outpatient Treatment of Venous Thromboembolism with Low-Molecular-Weight Heparin: An Economic Evaluation
Published: January 1st 2002 | Updated:
Anti-inflammatory Therapy Reduces Total Costs of Asthma Care Compared with Bronchodilation: The Asthma Outcomes Registry
Published: September 1st 2000 | Updated:
Prevalence of Cardiovascular Disease Risk Factors Among US Adults With Self-Reported Osteoarthritis: Data from the Third National Health and Nutrition Examination Survey
Published: October 1st 2002 | Updated:

Trending on AJMC

AAP Breaks With CDC, Maintains Broader 2026 Childhood and Adolescent Vaccine Schedule

Trulicity, Botox Headline Drugs Included in the Third Cycle of Medicare Price Negotiations

New Dermatologic Therapies Make Waves at Maui Derm 2026

CLL Breakthrough: 100% Efficacy Reported for VenR Retreatment

Experts Warn CDC Childhood Immunization Schedule Revisions Could Reduce Uptake, Erode Public Trust

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

© 2025 MJH Life Sciences^®

All rights reserved.